These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30427656)

  • 21. Discovery and characterization of New Delhi metallo-β-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.
    Kazi MI; Perry BW; Card DC; Schargel RD; Ali HB; Obuekwe VC; Sapkota M; Kang KN; Pellegrino MW; Greenberg DE; Castoe TA; Boll JM
    J Antimicrob Chemother; 2020 Oct; 75(10):2843-2851. PubMed ID: 32591801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
    Watkins RR; Deresinski S
    Expert Rev Anti Infect Ther; 2017 Oct; 15(10):893-895. PubMed ID: 28914107
    [No Abstract]   [Full Text] [Related]  

  • 23. Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.
    Djoko KY; Achard MES; Phan MD; Lo AW; Miraula M; Prombhul S; Hancock SJ; Peters KM; Sidjabat HE; Harris PN; Mitić N; Walsh TR; Anderson GJ; Shafer WM; Paterson DL; Schenk G; McEwan AG; Schembri MA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing
    Das S; Johnson A; McEntee L; Farrington N; Kirby A; Unsworth J; Jimenez-Valverde A; Kolamunnage-Dona R; Bousquet J; Alibaud L; Sable C; Zalacain M; Everett M; Hope W
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778549
    [No Abstract]   [Full Text] [Related]  

  • 26. An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.
    Pal A; Tripathi A
    Infect Genet Evol; 2013 Dec; 20():39-47. PubMed ID: 23954421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive
    Wang Y; Sun X; Kong F; Xia L; Deng X; Wang D; Wang J
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32213926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
    Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
    J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ruthenium complexes as prospective inhibitors of metallo-β-lactamases to reverse carbapenem resistance.
    Chen C; Yang K
    Dalton Trans; 2020 Oct; 49(40):14099-14105. PubMed ID: 32996954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Delhi Metallo-β-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India.
    Sekar R; Srivani S; Kalyanaraman N; Thenmozhi P; Amudhan M; Lallitha S; Mythreyee M
    J Glob Antimicrob Resist; 2019 Sep; 18():207-214. PubMed ID: 31181271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistance.
    Kinn PM; Chen DJ; Gihring TM; Schulz LT; Fox BC; McCreary EK; Lepak AJ
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):258-260. PubMed ID: 30344065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro and in vivo potential of metal-chelating agents as metallo-beta-lactamase inhibitors against carbapenem-resistant Enterobacterales.
    Omolabi KF; Reddy N; Mdanda S; Ntshangase S; Singh SD; Kruger HG; Naicker T; Govender T; Bajinath S
    FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 36521842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
    Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
    ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
    ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).
    Basu S; Singh AK; Nair GB
    Natl Med J India; 2010; 23(5):261-2. PubMed ID: 21250578
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
    Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dithiocarbamates: Efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem.
    Wang MM; Chu WC; Yang Y; Yang QQ; Qin SS; Zhang E
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3436-3440. PubMed ID: 30262427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of
    Davies DT; Leiris S; Zalacain M; Sprynski N; Castandet J; Bousquet J; Lozano C; Llanos A; Alibaud L; Vasa S; Pattipati R; Valige R; Kummari B; Pothukanuri S; De Piano C; Morrissey I; Holden K; Warn P; Marcoccia F; Benvenuti M; Pozzi C; Tassone G; Mangani S; Docquier JD; Pallin D; Elliot R; Lemonnier M; Everett M
    J Med Chem; 2020 Dec; 63(24):15802-15820. PubMed ID: 33306385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.